You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

Details for Patent: 9,763,577

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,763,577 protect, and when does it expire?

Patent 9,763,577 protects LUMISIGHT and is included in one NDA.

This patent has fourteen patent family members in seven countries.

Summary for Patent: 9,763,577

Title:	Imaging agent for detection of diseased cells
Abstract:	The present invention provides compositions and methods for imaging, for example, tumor resections.
Inventor(s):	Lee W. David, Bawendi Moungi G., Ferrer Jorge
Assignee:	Lumicell, Inc.
Application Number:	US14211014
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 9,763,577

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Lumicell	LUMISIGHT	pegulicianine acetate	POWDER;INTRAVENOUS	214511-001	Apr 17, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y		A METHOD COMPRISING ADMINISTERING PEGULICIANINE TO A HUMAN AND OBTAINING AN IMAGE OF A TUMOR BED AFTER TUMOR RESECTION TO DISTINGUISH IN SITU CANCER CELLS FROM HEALTHY CELLS	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,763,577

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014236561	⤷ Sign Up
Canada	2906056	⤷ Sign Up
China	105473051	⤷ Sign Up
European Patent Office	2967280	⤷ Sign Up
Japan	2016520339	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.